RHYTHM PHARMACEUTICALS, INC. (RYTM) Debt / Equity
- 2026-06-30: Debt/Equity Ratio 1.03.
- 2026-03-31: Debt/Equity Ratio 0.88.
- 2025-12-31: Debt/Equity Ratio 0.78.
- 2025-09-30: Debt/Equity Ratio 0.73.
Complete source-backed debt/equity ratio history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-06-30 | 1.03 |
| 2026-03-31 | 0.88 |
| 2025-12-31 | 0.78 |
| 2025-09-30 | 0.73 |
| 2025-06-30 | -9.22 |
| 2025-03-31 | 5.78 |
| 2024-12-31 | 5.05 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.78 |
| 2024-12-31 | 5.05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |